BTIG Initiates Coverage On ICU Medical with Buy Rating, Announces Price Target of $170

Benzinga Newsdesk www.benzinga.com Positive 53.4%

Neg 0% Neu 0% Pos 53.4%

BTIG analyst Sam Eiber initiates coverage on ICU Medical (NASDAQ:ICUI) with a Buy rating and announces Price Target of $170.